Korean Journal of Radiology

  • 제22권6호
  • /
  • Pages.944-950
  • /
  • 2021
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Percutaneous Microwave Ablation of Desmoid Fibromatosis

  • Alberto Martinez-Martinez (Department of Diagnostic Imaging, Virgen de las Nieves University Hospital) ;
  • Jade Garcia-Espinosa (Department of Diagnostic Imaging, Virgen de las Nieves University Hospital) ;
  • Antonio Jesus Lainez Ramos-Bossini (Department of Diagnostic Imaging, Virgen de las Nieves University Hospital) ;
  • Fernando Ruiz Santiago (Department of Diagnostic Imaging, Virgen de las Nieves University Hospital)
  • 투고 : 2020.06.11
  • 심사 : 2021.01.09
  • 발행 : 2021.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To demonstrate the feasibility of percutaneous microwave ablation in desmoid fibromatosis with respect to tumor volume control and improvement in the quality of life. Materials and Methods: Twelve microwave ablations were performed in 9 patients with a histological diagnosis of desmoid fibromatosis between January 2010 and January 2019. The study population included 6 female and 3 male, with an age range of 21-76 years (mean = 46.6 years; standard deviation [SD] = 19.3 years). The mean major axis of the tumors was 10.9 cm (SD = 5.2 cm) and mean lesion volume was 212.7 cm3 (SD = 213 cm3). Their anatomical distribution was as follows: 3 lesions in the thigh, 2 in the gluteus, 2 in the leg and 2 in the periscapular region. We evaluated the reduction in tumor volume and improvement in the quality of life based on the Eastern Cooperative Oncology Group (ECOG) scale. Results: An average tumor volume reduction of 70.4% (SD = 24.9) was achieved, while the quality of life (ECOG scale) improved in 88.9% of patients. Conclusion: Percutaneous microwave ablation may potentially be a safe, effective, and promising technique for controlling tumor volume and improving the quality of life in patients with desmoid fibromatosis.

키워드

참고문헌

  1. Otero S, Moskovic EC, Strauss DC, Benson C, Miah AB, Thway K, et al. Desmoid-type fibromatosis. Clin Radiol 2015;70:1038-1045
  2. Ng E, Tandon AA, Ho BC, Chong BK. Characterising benign fibrous soft-tissue tumours in adults: why is it so difficult and what do we need to know? Clin Radiol 2015;70:684-697
  3. Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 2003;14:181-190
  4. Fletcher C, Bridge J, Antonescu C, Mertens F. WHO classification of tumours: soft tissue and bone tumours, 5th. ed. Lyon: Editorial World Health Organization, 2020
  5. Smith K, Desai J, Lazarakis S, Gyorki D. Systematic review of clinical outcomes following various treatment options for patients with extraabdominal desmoid tumors. Ann Surg Oncol 2018;25:1544-1554
  6. Kasper B, Baumgarten C, Bonvalot S, Haas R, Haller F, Hohenberger P, et al. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise-a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. Eur J Cancer 2015;51:127-136
  7. Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol 2017;28:2399-2408
  8. Martinez Trufero J, Pajares Bernad I, Torres Ramon I, Hernando Cubero J, Pazo Cid R. Desmoid-type fibromatosis: who, when, and how to treat. Curr Treat Options Oncol 2017;18:29
  9. Cornelis F, Havez M, Lippa N, Al-Ammari S, Verdier D, Carteret T, et al. Radiologically guided percutaneous cryotherapy for soft tissue tumours: a promising treatment. Diagn Interv Imaging 2013;94:364-370
  10. Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol 2010;39:175-182
  11. Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, et al. Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience. AJR Am J Roentgenol 2016;207:190-195
  12. Redifer Tremblay K, Lea WB, Neilson JC, King DM, Tutton SM. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol 2019;120:366-375
  13. Bouhamama A, Lame F, Mastier C, Cuinet M, Thibaut A, Beji H, et al. Local control and analgesic efficacy of percutaneous cryoablation for desmoid tumors. Cardiovasc Intervent Radiol 2020;43:110-119
  14. Ilaslan H, Schils J, Joyce M, Marks K, Sundaram M. Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol 2010;39:169-173
  15. Cobianchi L, Ravetta V, Viera FT, Filisetti C, Siri B, Segalini E, et al. The challenge of extraabdominal desmoid tumour management in patients with Gardner's syndrome: radiofrequency ablation, a promising option. World J Surg Oncol 2014;12:361
  16. Avedian RS, Bitton R, Gold G, Butts-Pauly K, Ghanouni P. Is MR-guided high-intensity focused ultrasound a feasible treatment modality for desmoid tumors? Clin Orthop Relat Res 2016;474:697-704
  17. Bucknor MD, Rieke V. MRgFUS for desmoid tumors within the thigh: early clinical experiences. J Ther Ultrasound 2017;5:4
  18. Wang Y, Wang W, Tang J. Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: preliminary results. Int J Hyperthermia 2011;27:648-653
  19. Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics 2014;34:1344-1362
  20. Sheth PJ, Del Moral S, Wilky BA, Trent JC, Cohen J, Rosenberg AE, et al. Desmoid fibromatosis: MRI features of response to systemic therapy. Skeletal Radiol 2016;45:1365-1373
  21. Martin J, Athreya S. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome? Diagn Interv Radiol 2013;19:501-507
  22. De Cobelli F, Papa M, Panzeri M, Colombo M, Steidler S, Ambrosi A, et al. Percutaneous microwave ablation versus cryoablation in the treatment of T1a renal tumors. Cardiovasc Intervent Radiol 2020;43:76-83
  23. Niu L, Li J, Zeng J, Zhou L, Wang S, Zhou X, et al. Comparison of percutaneous cryoablation with microwave ablation in a porcine liver model. Cryobiology 2014;68:194-199
  24. Astani SA, Brown ML, Steusloff K. Comparison of procedure costs of various percutaneous tumor ablation modalities. Radiol Manage 2014;36:12-17
  25. Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010;21:S192-S203